Report

Benefit assessment of biotechnologically produced drugs for the treatment of rheumatoid arthritis

Status
Status: Commission completed
Project no.
A16-70
Last updated

Report documents

  1. Extract of the final report

    Benefit assessment of biotechnologically produced drugs for the treatment of rheumatoid arthritis

    published on
    Document type
    PDF document, 1 MB, EN, not accessible
  2. Final report

    Benefit assessment of biotechnologically produced drugs for the treatment of rheumatoid arthritis

    published on
    Document type
    PDF document, 14 MB, DE, not accessible
  3. Documentation of comments on the preliminary report

    Benefit assessment of biotechnologically produced drugs for the treatment of rheumatoid arthritis

    published on
    Document type
    PDF document, 6 MB, DE, not accessible
  4. Preliminary report

    Benefit assessment of biotechnologically produced drugs for the treatment of rheumatoid arthritis

    published on
    Document type
    PDF document, 12 MB, DE, not accessible
  5. Report plan version 1.0

    Benefit assessment of biotechnologically produced drugs for the treatment of rheumatoid arthritis

    published on
    Document type
    PDF document, 297 kB, DE, not accessible
  6. Documentation and evaluation of comments on the preliminary report plan

    Benefit assessment of biotechnologically produced drugs for the treatment of rheumatoid arthritis

    published on
    Document type
    PDF document, 5 MB, DE, not accessible
  7. Preliminary report plan

    Benefit assessment of biotechnologically produced drugs for the treatment of rheumatoid arthritis

    published on
    Document type
    PDF document, 215 kB, DE, not accessible

Press releases

Biologics in rheumatoid arthritis: better evidence, but direct comparisons still lacking

Only few differences between biologics detectable / Operationalization of outcomes can influence results

Project details

Project no.
A16-70
Commission
Commission awarded on 24.11.2016 by the Federal Joint Committee (GBA).
Report type
Report
Status
Commission completed
Department/Division
Drug Assessment
Topic
Muscles, bones and joints

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form